This session delves into the integration of biopharma and healthtech within the pharmaceutical industry. It explores how biotechnological advancements and digital health technologies are revolutionising drug development, patient diagnostics, and treatment monitoring. The module examines case studies of successful biopharma and healthtech collaborations, highlighting the role of data analytics, AI, and wearable technology in enhancing drug efficacy and patient care.

Charles Leong: Vice President at GHO Capital
Konrad Dobscheutz: Ex-National Director at NHS Innovation Accelerator

This module explores the drug life cycle's initial stages, including Drug Discovery and Preclinical Development, and proceeds to detail Clinical Trial Design. It emphasises the journey from identifying potential therapeutic compounds to the critical planning and execution of clinical trials. This comprehensive approach underlines the significance of ethical considerations, regulatory compliance, and the integration of technology in streamlining trial processes, ensuring data integrity, and safeguarding patient safety, offering a holistic view of drug development from conception to clinical evaluation.

Dr. Romillie Cruz, MD: Head of Medical Clinical Development, Senior Medical Director at Simbec-Orion
Evelyn Kamau: General Manager, DCT Strategy and Innovation Home Trial Services at Thermo Fisher Scientific

This module offers an overview of pharmaceutical regulations, concentrating on drug approval processes around the globe. It details the role of regulatory affairs in drug development, including marketing authorisation submissions, agency interactions, and compliance importance throughout the drug's lifecycle. Additionally, it addresses post-approval obligations, amendments, and regulatory document management.

Dr. Farzad Heidari: Regulatory Affairs Manager at BAP Pharma
Dr. Victor Lopez: Vice President, Medical Operations & General Manager AES

This module examines the crucial role of medical affairs in pharmaceutical companies, focusing on their involvement in scientific communication, medical education, and stakeholder engagement. It teaches how to effectively communicate complex scientific information to diverse audiences, including healthcare professionals, patients, and regulatory bodies. The module also covers strategies for building and maintaining relationships with key stakeholders.

Dr. Mayur Joshi: Director at Global Medical Affairs Consulting; ex-Global Medical Head at Novartis
Dr. Rav Seeruthun: Chief Medical Officer at Health-equity.AI; ex-VP US Medical Affairs at Genentech

This module introduces health economics and market access, key to pharmaceutical product commercialisation. It covers health economics principles, such as cost-effectiveness, budget impact analyses, and pricing strategies, and discusses reimbursement pathways and negotiations with healthcare payers. Fellows will learn about the importance of demonstrating value to stakeholders and using health economic data in market access strategies. The module also highlights global variations in healthcare systems and market access requirements.

Stuart Carroll: Director Market Access and Policy Affairs at Moderna
Dr. Faiz Shivji: Global Commercial Strategy Director, Immuno-Oncology, Bispecifics at AstraZeneca

This module delves into marketing and selling pharmaceutical products, highlighting product positioning, brand management, and campaign development for various stakeholders. It examines digital and traditional sales strategies, ethical marketing practices, regulatory compliance, and the influence of market access on marketing strategies. Fellows will learn about pharmaceutical sales dynamics and customer relationship management's significance.

Dr. Shaneil Sonecha: Country Medical Director at CSL Vifor (UK)
‍Nicolas Schmitz: Senior Manager, Strategic Market Analyst at KBI BioPharma

The final week culminates with our BiteLabs: Pharma and Life Sciences Summit event, where we host the pharma and life sciences industry, topical panel discussions and an oppertunity for our fellows to  present the individual and/or group projects they have been working on during their 8 weeks fellowship programme.

Our summit event is a great opportunity for our fellows to become a part of the Pharma and Life Sciences industry by networking and raising their profiles amongst the top industry leaders.
‍
You will ralso eceive your certificates and be formally initiated into the BiteLabs Pharma & LifeSciences Alumni Community.